6-31592893-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 1P and 3B. PP5BP4BS1_SupportingBS2_Supporting
The NM_147130.3(NCR3):c.-172G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0216 in 680,664 control chromosomes in the GnomAD database, including 294 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: 𝑓 0.023 ( 75 hom., cov: 31)
Exomes 𝑓: 0.021 ( 219 hom. )
Consequence
NCR3
NM_147130.3 5_prime_UTR
NM_147130.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.02
Genes affected
NCR3 (HGNC:19077): (natural cytotoxicity triggering receptor 3) The protein encoded by this gene is a natural cytotoxicity receptor (NCR) that may aid NK cells in the lysis of tumor cells. The encoded protein interacts with CD3-zeta (CD247), a T-cell receptor. A single nucleotide polymorphism in the 5' untranslated region of this gene has been associated with mild malaria suceptibility. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP5
Variant 6-31592893-C-T is Pathogenic according to our data. Variant chr6-31592893-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 1803723.Status of the report is no_assertion_criteria_provided, 0 stars.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). . Strength limited to SUPPORTING due to the PP5.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0233 (3539/152184) while in subpopulation AMR AF= 0.039 (595/15262). AF 95% confidence interval is 0.0364. There are 75 homozygotes in gnomad4. There are 1577 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 75 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NCR3 | NM_147130.3 | c.-172G>A | 5_prime_UTR_variant | 1/4 | ENST00000340027.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NCR3 | ENST00000340027.10 | c.-172G>A | 5_prime_UTR_variant | 1/4 | 1 | NM_147130.3 | P2 | ||
NCR3 | ENST00000376072.7 | c.-172G>A | 5_prime_UTR_variant | 1/4 | 1 | A2 | |||
NCR3 | ENST00000376073.8 | c.-172G>A | 5_prime_UTR_variant | 1/4 | 1 | A2 | |||
NCR3 | ENST00000491161.1 | n.67G>A | non_coding_transcript_exon_variant | 1/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0233 AC: 3540AN: 152066Hom.: 75 Cov.: 31
GnomAD3 genomes
AF:
AC:
3540
AN:
152066
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0212 AC: 11182AN: 528480Hom.: 219 Cov.: 6 AF XY: 0.0200 AC XY: 5599AN XY: 280500
GnomAD4 exome
AF:
AC:
11182
AN:
528480
Hom.:
Cov.:
6
AF XY:
AC XY:
5599
AN XY:
280500
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0233 AC: 3539AN: 152184Hom.: 75 Cov.: 31 AF XY: 0.0212 AC XY: 1577AN XY: 74390
GnomAD4 genome
AF:
AC:
3539
AN:
152184
Hom.:
Cov.:
31
AF XY:
AC XY:
1577
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Malaria, severe, susceptibility to Pathogenic:1
Pathogenic, no assertion criteria provided | research | Center for Global Health, University of New Mexico Health Sciences Center, University of New Mexico | Dec 06, 2022 | CC is wild type in the Luo (Kenya) population, TT is homozygous mutant. TT increases susceptibility to longitudinal (over 36 months) falciparum malaria episodes in children less than 48 months of age. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at